Literature DB >> 24382652

AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.

Ophélie Vacca1, Marie Darche, David V Schaffer, John G Flannery, José-Alain Sahel, Alvaro Rendon, Deniz Dalkara.   

Abstract

Formation and maintenance of the blood-retinal barrier (BRB) is required for proper vision and breaching of this barrier contributes to the pathology in a wide variety of retinal conditions such as retinal detachment and diabetic retinopathy. Dystrophin Dp71 being a key membrane cytoskeletal protein, expressed mainly in Müller cells, its absence has been related to BRB permeability through delocalization and down-regulation of the AQP4 and Kir4.1 channels. Dp71-null mouse is thus an excellent model to approach the study of retinal pathologies showing blood-retinal barrier permeability. We aimed to investigate the participation of Müller cells in the BRB and in the inner limiting membrane of Dp71-null mice compared with wild-type mice in order to understand how these barriers work in this model of permeable BRB. To this aim, we used an Adeno-associated virus (AAV) variant, ShH10-GFP, engineered to target Müller cells specifically. ShH10 coding GFP was introduced by intravitreal injection and Müller cell transduction was studied in Dp71-null mice in comparison to wild-type animals. We show that Müller cell transduction follows a significantly different pattern in Dp71-null mice indicating changes in viral cell-surface receptors as well as differences in the permeability of the inner limiting membrane in this mouse line. However, the compromised BRB of the Dp71-null mice does not lead to virus leakage into the bloodstream when the virus is injected intravitreally - an important consideration for AAV-mediated retinal gene therapy.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  AAV; Dystrophin Dp71; Müller cell; blood-retinal barrier; inner limiting membrane

Mesh:

Substances:

Year:  2013        PMID: 24382652     DOI: 10.1002/glia.22617

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  21 in total

1.  Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina.

Authors:  Shannon E Boye; John J Alexander; C Douglas Witherspoon; Sanford L Boye; James J Peterson; Mark E Clark; Kristen J Sandefer; Chris A Girkin; William W Hauswirth; Paul D Gamlin
Journal:  Hum Gene Ther       Date:  2016-08       Impact factor: 5.695

2.  Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease.

Authors:  Ophélie Vacca; Brahim El Mathari; Marie Darche; José-Alain Sahel; Alvaro Rendon; Deniz Dalkara
Journal:  J Vis Exp       Date:  2015-04-19       Impact factor: 1.355

3.  Vitreal delivery of AAV vectored Cnga3 restores cone function in CNGA3-/-/Nrl-/- mice, an all-cone model of CNGA3 achromatopsia.

Authors:  Wei Du; Ye Tao; Wen-Tao Deng; Ping Zhu; Jie Li; Xufeng Dai; Yuxin Zhang; Wei Shi; Xuan Liu; Vince A Chiodo; Xi-Qin Ding; Chen Zhao; Stylianos Michalakis; Martin Biel; Zuoming Zhang; Jia Qu; William W Hauswirth; Ji-Jing Pang
Journal:  Hum Mol Genet       Date:  2015-04-08       Impact factor: 6.150

4.  Noninvasive gene delivery to foveal cones for vision restoration.

Authors:  Hanen Khabou; Marcela Garita-Hernandez; Antoine Chaffiol; Sacha Reichman; Céline Jaillard; Elena Brazhnikova; Stéphane Bertin; Valérie Forster; Mélissa Desrosiers; Céline Winckler; Olivier Goureau; Serge Picaud; Jens Duebel; José-Alain Sahel; Deniz Dalkara
Journal:  JCI Insight       Date:  2018-01-25

5.  The primate model for understanding and restoring vision.

Authors:  Serge Picaud; Deniz Dalkara; Katia Marazova; Olivier Goureau; Botond Roska; José-Alain Sahel
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

6.  Dystrophin Dp71 Isoforms Are Differentially Expressed in the Mouse Brain and Retina: Report of New Alternative Splicing and a Novel Nomenclature for Dp71 Isoforms.

Authors:  Jorge Aragón; Mayram González-Reyes; José Romo-Yáñez; Ophélie Vacca; Guadalupe Aguilar-González; Alvaro Rendón; Cyrille Vaillend; Cecilia Montañez
Journal:  Mol Neurobiol       Date:  2017-01-27       Impact factor: 5.590

7.  Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates.

Authors:  M A Kotterman; L Yin; J M Strazzeri; J G Flannery; W H Merigan; D V Schaffer
Journal:  Gene Ther       Date:  2014-12-11       Impact factor: 5.250

8.  Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1.

Authors:  Nundehui Díaz-Lezama; Zhijian Wu; Elva Adán-Castro; Edith Arnold; Miguel Vázquez-Membrillo; David Arredondo-Zamarripa; Maria G Ledesma-Colunga; Bibiana Moreno-Carranza; Gonzalo Martinez de la Escalera; Peter Colosi; Carmen Clapp
Journal:  Lab Invest       Date:  2015-11-16       Impact factor: 5.662

Review 9.  The internal limiting membrane: Roles in retinal development and implications for emerging ocular therapies.

Authors:  Kevin Y Zhang; Thomas V Johnson
Journal:  Exp Eye Res       Date:  2021-03-20       Impact factor: 3.467

Review 10.  Gene therapy of inherited retinal degenerations: prospects and challenges.

Authors:  Ivana Trapani; Sandro Banfi; Francesca Simonelli; Enrico M Surace; Alberto Auricchio
Journal:  Hum Gene Ther       Date:  2015-04       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.